Differences in the expression of small RNAs, called microRNAs, which may be useful for identifying patients with idiopathic pulmonary fibrosis (IPF)…
Articles by Patricia Inácio, PhD
Blocking a particular pathway — called c-Jun N-terminal Kinase (JNK) — may reduce lung remodeling and fibrosis, researchers said in a multi-part study…
Researchers may have discovered a key mechanism underlying pulmonary fibrosis (PF) — the failure of a particular group of lung stem…
Inhibiting PARP-1 protein expression eased several symptoms of lung fibrosis in a mice model of the disease. These results suggest that PARP-1 inhibitors…
Statins provide beneficial effects, including decreased death risk, in a large and well-defined cohort of patients with idiopathic pulmonary fibrosis (IPF),…
Researchers have found, in mice with pulmonary fibrosis and with dominant immune response mediated by immune Th2 cells (T-helper cells), that aerobic…
Certain distinctive genetic differences or variations, including in genes involved in mucus production, were found to be significantly predominant in European…
High levels of gremlin-1, a protein important in lung and other organ development, promoted a more aggressive fibrotic response in a…
A recent study published in the journal PLOS One, found two members of a class of proteins called surfactant proteins (SPs) at increased…
P-Rex1 is a potential novel therapeutic target for pulmonary fibrosis (PF), according to the results of a new study, “…